A modified synthesis of iodoazidoaryl prazosin.
Article Details
- CitationCopy to clipboard
Andrus MB, Mettath SN, Song C
A modified synthesis of iodoazidoaryl prazosin.
J Org Chem. 2002 Nov 15;67(23):8284-6.
- PubMed ID
- 12423172 [ View in PubMed]
- Abstract
The antihypertension agent iodoazidoaryl prazosin (IAAP) has been made using a convergent route involving addition of an acylated piperazine 7 to 2-chloroquinazoline 5. IAAP has been shown to function as a multidrug resistance (MDR) reversal agent and bind to P-glycoprotein, a transmembrane transport protein. A study is also reported involving palladium-catalyzed substitution with amine heterocycles. With N,N-bis(2,6-diisopropyl)dihydroimidazolium chloride (10) as the ligand (2 mol %) for palladium(II) acetate (2 mol %) in THF at room temperature, morpholine added to 5 in 81% yield.
DrugBank Data that Cites this Article
- Drug Transporters
Drug Transporter Kind Organism Pharmacological Action Actions Prazosin P-glycoprotein 1 Protein Humans UnknownSubstrateInhibitorModulatorDetails